Has Haitham Elconsul, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,546 in general payments to Haitham Elconsul, MD across 94 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Haitham Elconsul, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Haitham Elconsul, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Haitham Elconsul, MD

Hospitalist · Las Vegas, NVNPI 1609038363

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 79.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $422 and has fallen 78.8% since, to $89 in 2024. Among hospitalist clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,546in general payments, 2019–2025

Across 94 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Johnson & Johnson$105
Pfizer$84
Merck$80
E.r. Squibb & Sons, L.L.C.$26
AstraZeneca$17

What the payments were for

Food & beverage$1,546100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	77	$1,233
Johnson & Johnson	6	$105
Pfizer	4	$84
Merck	4	$80
E.r. Squibb & Sons, L.L.C.	2	$26
AstraZeneca	1	$17

How this compares

$1,546 in reported general payments places this provider in the 95th percentile of 191 hospitalist providers in Nevada.

See all hospitalist providers in Nevada →

Medicare billing

Part B allowed, 2024

$260,292

Medicare patients

284

Services billed

2,468

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	17	$9,192
Amiodarone Hcl	18	$161
Pantoprazole Sodium	23	$117
Atorvastatin Calcium	26	$103
ClopidogrelClopidogrel Bisulfate	11	$77
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	17	$76
Furosemide	16	$56
Famotidine	11	$35
Tamsulosin Hcl	13	$31
Metoprolol Tartrate	16	$27
Amlodipine Besylate	21	$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$84	$9,19217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 191 hospitalist providers in Nevada.

Other hospitalist in Las Vegas

Manlin JinLas Vegas$2K
Sean KumarLas Vegas$2K
Caitlyn WaltersLas Vegas$2K
Swati WadhwaniLas Vegas$2K
Kamran KhanLas Vegas$2K
Jay KumarLas Vegas$2K
Sikisam MagoyagLas Vegas$1K
Vishal ShahLas Vegas$840
Andrew JonesLas Vegas$816
Brandon CarneyLas Vegas$743

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →